Frontiers in Pharmacology,
Год журнала:
2022,
Номер
13
Опубликована: Март 17, 2022
Major
depressive
disorder
(MDD)
is
a
chronic,
remitting
and
debilitating
disease
the
etiology
of
MDD
highly
complicated
that
involves
genetic
environmental
interactions.
Despite
many
pharmacotherapeutic
options,
patients
remain
poorly
treated
development
effective
treatments
remains
high
priority
in
field.
LPM570065
potent
5-hydroxytryptamine
(5-HT),
norepinephrine
(NE)
dopamine
(DA)
triple
reuptake
inhibitor
both
preclinical
clinical
results
demonstrate
significant
efficacy
against
MDD.
This
study
extends
previous
findings
to
examine
effects
underlying
mechanisms
on
stress
vulnerability
using
"two-hit"
mouse
model.
The
model
used
adult
mice
had
experienced
early
life
maternal
separation
(MS)
for
social
defeat
(SDS)
then
they
were
evaluated
three
behavioral
assays:
sucrose
preference
test,
tail
suspension
test
forced
swimming
test.
For
mechanistic
studies,
methylation-specific
differentially
expressed
genes
hippocampal
tissue
ventral
tegmental
area
(VTA)
analyzed
by
whole-genome
transcriptome
analysis
along
with
next-generation
bisulfite
sequencing
analysis,
followed
RT-PCR
pyrophosphate
confirm
gene
expression
methylation.
significantly
reversed
depressive-like
behaviors
Morphologically,
increased
density
dendritic
spines
CA1
neurons.
Hypermethylation
downregulation
oxytocin
receptor
(
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(19), С. 11076 - 11076
Опубликована: Сен. 21, 2022
Depression
and
anxiety
disorders
are
the
two
most
prevalent
psychiatric
diseases
that
affect
hundreds
of
millions
individuals
worldwide.
Understanding
etiology
related
mechanisms
is
great
importance
might
yield
new
therapeutic
strategies
to
treat
these
effectively.
During
past
decades,
a
growing
number
studies
have
pointed
out
stress-induced
inflammatory
response
in
amygdala,
kernel
region
for
processing
emotional
stimuli,
as
potentially
critical
contributor
pathophysiology
depression
disorders.
In
this
review,
we
first
summarized
recent
progress
from
both
animal
human
toward
understanding
causal
link
between
inflammation
disorders,
with
particular
emphasis
on
findings
showing
effect
functional
changes
neurons
at
levels
ranging
molecular
signaling,
cellular
function,
synaptic
plasticity,
neural
circuit
behavior,
well
their
contributions
pathology
inflammation-related
Finally,
concluded
by
discussing
some
difficulties
surrounding
current
research
propose
issues
worth
future
study
field.
Signal Transduction and Targeted Therapy,
Год журнала:
2025,
Номер
10(1)
Опубликована: Янв. 2, 2025
Abstract
Radiopharmaceuticals
involve
the
local
delivery
of
radionuclides
to
targeted
lesions
for
diagnosis
and
treatment
multiple
diseases.
Radiopharmaceutical
therapy,
which
directly
causes
systematic
irreparable
damage
cells,
has
attracted
increasing
attention
in
refractory
diseases
that
are
not
sensitive
current
therapies.
As
Food
Drug
Administration
(FDA)
approvals
[
177
Lu]Lu-DOTA-TATE,
Lu]Lu-PSMA-617
their
complementary
diagnostic
agents,
namely,
68
Ga]Ga-DOTA-TATE
Ga]Ga-PSMA-11,
radiopharmaceutical-based
theranostics
(radiotheranostics)
being
increasingly
implemented
clinical
practice
oncology,
lead
a
new
era
radiopharmaceuticals.
The
generation
radiopharmaceuticals
utilizes
targeting
vector
achieve
accurate
avoid
off-target
deposition,
making
it
possible
improve
efficiency
biosafety
tumour
therapy.
Numerous
studies
have
focused
on
developing
novel
broader
range
disease
targets,
demonstrating
remarkable
vivo
performance.
These
include
high
tumor
uptake,
prolonged
retention
time,
favorable
pharmacokinetic
properties
align
with
standards.
While
radiotheranostics
been
widely
applied
applications
now
expanding
neurodegenerative
diseases,
cardiovascular
inflammation.
Furthermore,
radiotheranostic-empowered
precision
medicine
is
revolutionizing
cancer
paradigm.
Diagnostic
play
pivotal
role
patient
stratification
planning,
leading
improved
therapeutic
outcomes
radionuclide
This
review
offers
comprehensive
overview
evolution
radiopharmaceuticals,
including
both
FDA-approved
clinically
investigated
explores
mechanisms
cell
death
induced
by
It
emphasizes
significance
future
prospects
theranostic-based
advancing
medicine.
Nature Communications,
Год журнала:
2023,
Номер
14(1)
Опубликована: Апрель 17, 2023
Abstract
Nucleus-
and
cell-specific
interrogation
of
individual
basal
forebrain
(BF)
cholinergic
circuits
is
crucial
for
refining
targets
to
treat
comorbid
chronic
pain-like
depression-like
behaviour.
As
the
ventral
pallidum
(VP)
in
BF
regulates
pain
perception
emotions,
we
aim
address
role
VP-derived
hyperalgesia
behaviour
mouse
model.
In
male
mice,
VP
neurons
innervate
local
non-cholinergic
modulate
downstream
basolateral
amygdala
(BLA)
through
nicotinic
acetylcholine
receptors.
These
are
mobilized
by
stimuli
become
hyperactive
during
persistent
pain.
Acute
stimulation
VP-BLA
projection
reduces
threshold
naïve
mice
whereas
inhibition
elevated
states.
Multi-day
repetitive
modulation
pathway
Therefore,
implicated
Biomedicines,
Год журнала:
2022,
Номер
10(5), С. 1005 - 1005
Опубликована: Апрель 27, 2022
Major
depressive
disorder
(MDD)
is
a
common
neuropsychiatric
affecting
the
mood
and
mental
well-being.
Its
pathophysiology
remains
elusive
due
to
complexity
heterogeneity
of
this
that
affects
millions
individuals
worldwide.
Chronic
stress
frequently
cited
as
one
risk
factors
for
MDD.
To
date,
conventional
monoaminergic
theory
(serotonin,
norepinephrine,
and/or
dopamine
dysregulation)
has
received
most
attention
in
treatment
MDD,
all
available
classes
antidepressants
target
these
systems.
However,
contributions
other
neurotransmitter
systems
MDD
have
been
widely
reported.
Emerging
preclinical
clinical
findings
reveal
maladaptive
glutamatergic
neurotransmission
might
underlie
thus
revealing
its
critical
role
neurobiology
therapeutic
target.
Aiming
beyond
hypothesis,
studies
neurobiological
mechanisms
underlying
stress-induced
impairment
AMPA
(a-amino-3-hydroxy-5-methyl-4-isoxazole
propionic
acid)-glutamatergic
brain
could
provide
novel
insights
development
new
generation
without
detrimental
side
effects.
Here,
authors
reviewed
recent
literature
focusing
on
AMPA-glutamatergic
responses
emotional
mood-associated
regions,
including
hippocampus,
amygdala,
prefrontal
cortex,
nucleus
accumbens
periaqueductal
gray.
Theranostics,
Год журнала:
2024,
Номер
14(9), С. 3653 - 3673
Опубликована: Янв. 1, 2024
:
Recent
evidence
highlights
the
pivotal
role
of
mitochondrial
dysfunction
in
mood
disorders,
but
mechanism
involved
remains
unclear.
We
studied
whether
Hippo/YAP/14-3-3η
signaling
pathway
mediates
abnormalities
that
result
onset
major
depressive
disorder
(MDD)
a
mouse
model.
CNS Neuroscience & Therapeutics,
Год журнала:
2024,
Номер
30(4)
Опубликована: Апрель 1, 2024
Abstract
Background
Depression
is
a
serious
mental
disorder
and
the
most
prevalent
cause
of
disability
suicide
worldwide.
Chronic
unpredictable
mild
stress
(CUMS)
can
lead
to
significant
acceleration
depression
development.
Quercetin
(Que)
flavonoid
compound
with
wide
range
pharmacological
effects.
Recent
studies
have
shown
that
quercetin
improve
CUMS‐induced
depression‐like
behavior,
but
mechanism
its
improvement
still
unclear.
α2δ‐1
regulatory
subunit
voltage‐gated
calcium
channel,
which
interact
N‐methyl‐D‐aspartate
receptor
(NMDAR)
form
complex.
Objective
In
this
study,
we
found
Que
could
inhibit
increase
NMDAR
expression
in
rat
hypothalamus
induced
by
CUMS.
pain,
chronic
hypertension
other
interacts
complex,
subsequently
affects
level
NMDAR.
Consequently,
present
study
aimed
investigate
antidepressant
effect
vivo
vitro
explore
action
terms
interaction
between
Methods
Rats
were
randomly
exposed
two
stressors
every
day
for
4
weeks
establish
CUMS
model,
then
sucrose
preference
test
(SPT),
forced
swimming
(FST),
tail
suspension
(TST),
open
field
(OFT)
performed
detect
behavior
rats,
so
as
evaluate
whether
model
was
successfully
established
on
rats.
Experimental
techniques
such
serum
enzyme‐linked
immunosorbent
assay
(ELISA),
immunofluorescence,
Western
blot,
co‐immunoprecipitation,
well
experiments,
used
mechanisms
exerts
Results
Behavioral
ELISA
results
showed
produce
reduction
excitability
hypothalamic–pituitary–adrenal
(HPA)
axis
rats
improvements
their
depressive
behavior.
co‐immunoprecipitation
experiments
produced
decrease
NMDAR1
levels
interfered
binding.
addition,
neural
regulation
PC12
cells
knocked
out
gene
further
verified.
Cellular
demonstrated
led
reversal
up‐regulation
corticosterone‐injured
cells,
while
had
no
effects
knockout.
Conclusions
has
good
significantly
caused
It
inhibiting
α2δ‐1,
interfering
NMDAR,
reducing
HPA
axis.